Evonetix
evonetix is seeking to develop and commercialise a new approach to the synthesis of DNA.
Total raised
€49M
€49,324,826
Funding rounds
2
Investors
7
distinct backers
Active since
2020-02
latest 2023-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood30
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 11y since founding
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-07 | Series B | €22M | Cambridge Consultants,Civilization Ventures,DCVC,Foresite Capital,Molten Ventures,Morningside+1 more | View deal → |
| 2020-02-03 | Series B | €27M | Foresite Capital | View deal → |